In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ivermectin B1a Drug Master File in Korea (Ivermectin B1a KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ivermectin B1a. The MFDS reviews the Ivermectin B1a KDMF as part of the drug registration process and uses the information provided in the Ivermectin B1a KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ivermectin B1a KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ivermectin B1a API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ivermectin B1a suppliers with KDMF on PharmaCompass.